Parasites have developed ingenious strategies to change their host’s biology. A research team led by Michael H. Hsieh, M.D., Ph.D., Director of the Clinic for Adolescent and Adult PedIatric OnseT UroLogy (CAPITUL) at Children’s National, turned the tables on the pesky parasites by using their proteins to provide therapeutic benefits. The team’s paper, “Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Chemotherapy-Induced Hemorrhagic Cystitis and Bladder Hypersensitivity,” won the “Best Basic Science” award–a coveted national honor–during the Pediatric Urology Fall Congress in September. “Our work represents the first time that a uropathogen-derived host modulatory molecule has been therapeutically exploited in bladder disease models,” Dr. Hsieh and co-authors write.
LATEST TWEETS FROM INNOVATION DISTRICT
Today, on #WorldCancerResearchDay, we are excited to announce that @ChildrensNatl in Washington, DC, is our latest (and first pediatric) Focused Ultrasound Center of Excellence. https://childrensnational.org/news-and-events/childrens-newsroom/2020/first-pediatric-hospital-designated-coe
4 days until the #CNNIAIDSymposium! Register today at https://ctsicn.org/cn-niaid and view the full agenda. Epidemiology and Clinical Manifestations at 12:40 pm ET #healthdisparities #COVIDー19 #SARSCoV2 #REOPENSCHOOLS